Report Details:
15 Companies Covered
200 Pages
Growing Biopharmaceutical Demand Will Positively Impact the Global Albumin (as Excipient) Market at a CAGR of 5.91% During the Forecast Period 2025 to 2035
Market Research Future (MRFR) has published a cooked research report on the “Global Albumin (as Excipient) Market” that contains information from 2019 to 2035. The Albumin (as Excipient) Market is estimated to register a CAGR of 5.91% during the forecast period of 2025 to 2035.
MRFR recognizes the following companies as the key players in the Global Albumin (as Excipient) Market: LFB, Proliant Biologicals, Octapharma, Grifols, Ventria Bioscience, Asian Biologics, Bio Products Laboratory, Kedrion, Baxter, CSL Behring, and Hualan Biological Engineering.
Market Highlights
The Global Albumin (as Excipient) Market is expected to register a CAGR of 5.91% during the forecast period and is estimated to reach USD 1.89 billion by 2035, up from USD 1.01 billion in 2024.
Market growth is primarily driven by the rising demand for biopharmaceuticals and biosimilars, advancements in drug formulation technologies, and the increasing prevalence of chronic diseases. Albumin’s unique properties — such as its biocompatibility, ability to enhance drug stability, and improve bioavailability — make it a preferred excipient in therapeutic drug formulations.
The pharmaceutical segment accounted for the largest share in 2024, valued at USD 0.45 billion, and is projected to reach USD 0.83 billion by 2035, reflecting albumin’s extensive use in protein therapeutics, vaccine stabilization, and drug delivery systems. Technological advancements like nanotechnology and recombinant albumin production are expected to further enhance albumin’s role in modern drug formulations.
Additionally, the regulatory support for biologics, especially from bodies such as the U.S. FDA, is encouraging faster approvals for biologics that utilize albumin as an excipient. The market also benefits from the rise of personalized medicine and R&D investments targeting sustainable and efficient albumin production methods.
Segment Analysis
The Global Albumin (as Excipient) Market has been segmented based on Application, Formulation Type, Source, and End Use.
By Application: Pharmaceuticals dominated in 2024, followed by Biotechnology and Diagnostics.
By Formulation Type: Injectables held a major share due to their therapeutic importance, while lyophilized forms are gaining traction for their stability and extended shelf life.
By Source: Human Serum Albumin leads the market, with Recombinant Albumin witnessing increasing demand due to its purity and consistency.
By End Use: Hospitals and Pharmaceutical Companies are the primary end users, reflecting the growing adoption of albumin in advanced drug delivery systems.
Region Analysis
By Region, the Albumin (as Excipient) Market is segmented into North America, Europe, Asia-Pacific, South America, and the Middle East & Africa. North America led the market with a valuation of USD 0.36 billion in 2024, projected to reach USD 0.67 billion by 2035, owing to a robust biopharmaceutical sector and strong R&D infrastructure. Europe followed closely, supported by high investments in biologics and drug innovation. Asia-Pacific is expected to grow fastest, from USD 0.20 billion in 2024 to USD 0.38 billion by 2035, driven by expanding healthcare infrastructure and rising biologic drug manufacturing.
Key Findings of the Study
- The Global Albumin (as Excipient) Market is expected to reach USD 1.89 billion by 2035, growing at a CAGR of 5.91% from 2025 to 2035.
- North America dominated the market in 2024, while Asia-Pacific is projected to grow at the highest rate.
- Based on the Application, the Pharmaceutical segment held the largest share in 2024.
- Based on the Source, Human Serum Albumin dominated the market, with Recombinant Albumin emerging as a sustainable alternative.
- LFB, Proliant Biologicals, Octapharma, Grifols, and CSL Behring are among the leading players focusing on R&D, mergers, and partnerships to strengthen their market position.
Report Link- https://www.marketresearchfuture.com/reports/albumin-market-7442
